Mariner
RVMD icon

Mariner’s Revolution Medicines RVMD Stock Holding History

Mariner’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.2M Buy
+43,794
New +$6.4M 0.01% 824
2025
Q2 		– Sell
-7,908
Closed -$280K – 3651
2025
Q1 		$280K Sell
7,908
-131
-2% -$5.32K ﹤0.01% 2685
2024
Q4 		$352K Sell
8,039
-689
-8% -$34.8K ﹤0.01% 2482
2024
Q3 		$395K Buy
8,728
+2,411
+38% +$105K ﹤0.01% 2340
2024
Q2 		$245K Buy
+6,317
New +$236K ﹤0.01% 2615

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mariner's RVMD Position: Q2 2026 in Review

Mariner opened a new position in Revolution Medicines (RVMD) in Q2 2026: 43,794 shares worth $8.2M. The stake represents 0.01% of the portfolio and ranks #824 among its holdings. This is a return to the name: Mariner previously reported a position in RVMD as recently as Q1 2025.

Mariner first reported a position in RVMD in Q2 2024 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mariner held 43,794 shares of Revolution Medicines worth $8.2M as of Q2 2026.
  • Revolution Medicines was a new Mariner position in Q2 2026.
  • Revolution Medicines made up 0.01% of Mariner's portfolio in Q2 2026, its #824 holding.
  • Mariner first reported a position in Revolution Medicines in Q2 2024 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.